3 small cap ASX shares to watch

Keep an eye on these small cap shares…

| More on:
asx share price on watch represented by group of prople all looking through magnifying glasses

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps.

Three small cap shares that could be worth adding to your watchlist are listed below. Here's what you need to know about them:

Avita Medical Ltd (ASX: AVH)

The first small cap ASX share to look at is Avita Medical. It is a global regenerative medicine company best known for its Recell system. This is a spray-on skin treatment used for burns victims. It is also looking to use its system to treat vitiligo and is working on a project with Houston Methodist Research Institute on reversing cellular ageing. Bell Potter is positive on the company. It has a speculative buy rating and $9.80 price target on its shares.

Damstra Holdings Ltd (ASX: DTC)

Another small cap to watch is Damstra. It is a growing integrated workplace management solutions provider. Its cloud-based workplace management platform is used by businesses globally to track, manage, and protect their workers and assets. It recently reported that annual recurring revenue (ARR) reached $35 million at the end of June. This was up 65% over the prior corresponding period. Pleasingly, this is still only a small slice of its total addressable market (TAM). Management estimates that its TAM will be worth US$20 billion by 2022. In response to its update, Shaw and Partners retained its buy rating and $1.88 price target.

Mach7 Technologies Ltd (ASX: M7T)

A final small cap ASX share to watch is Mach7. It is a medical imaging data management solutions provider that allows users to create a clear and complete view of the patient. Users then use this to help them inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Demand for this type of software continues to grow thanks to industry tailwinds such as telehealth. The company estimates that its TAM is currently US$2.75 billion. This is materially more than the annual revenue of $19 million and $19.5 million it expects to report in FY 2021. Morgans is a fan of the company. It currently has an add rating and $1.56 price target on the company's shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Avita Medical Limited, Damstra Holdings Ltd, and MACH7 FPO. The Motley Fool Australia owns shares of and has recommended Damstra Holdings Ltd. The Motley Fool Australia has recommended Avita Medical Limited and MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Small Cap Shares

Three young people in business attire sit around a desk and discuss.
Small Cap Shares

3 ASX penny stocks I don't think will be below 80 cents much longer

These sub-dollar shares are all capable of smashing through to another level, say experts.

Read more »

Kid on a skateboard with cardboard wings soars along the road.
Small Cap Shares

Want to make big returns? ASX small-cap shares are poised to outperform

Smaller businesses could be compelling investments today, according to an expert.

Read more »

The Two little girls smiling upside down on a bed.
Small Cap Shares

Where I'd invest $5,000 into ASX small-cap shares aiming for big growth

I love the potential of how big these small stocks could become.

Read more »

A young woman makes an online travel booking as she sits on some steps with her suitcase next to her.
Opinions

I think this ASX small-cap share can soar in 2024

This stock could keep travelling higher over time.

Read more »

Three young people in business attire sit around a desk and discuss.
Opinions

3 reasons why I'd buy small-cap shares over ASX blue chips in 2024

I’m excited by the potential of small stocks.

Read more »

three children wearing superhero costumes, complete with masks, pose with hands on hips wearing capes and sneakers on a running track.
Small Cap Shares

3 'attractive' small-cap ASX shares ready to rocket in 2024

They ended 2023 with a bang, but the gurus at IML reckon the smaller ASX businesses have more catching up…

Read more »

A couple stares at the tv in shock, one holding the remote up ready to press.
Small Cap Shares

Why Bell Potter says these ASX small cap shares are buys

The broker has only good things to say about these stocks.

Read more »

Two kids in superhero capes.
Small Cap Shares

'Substantial returns over years ahead': 2 ASX small caps starting 2024 with a bang

Smaller companies have struggled over the past two years compared to their larger rivals, but this year could see the…

Read more »